110 related articles for article (PubMed ID: 19857971)
1. Novel estrogen receptor (ER) modulators: carbamate and thiocarbamate derivatives with m-carborane bisphenol structure.
Ohta K; Ogawa T; Suzuki T; Ohta S; Endo Y
Bioorg Med Chem; 2009 Dec; 17(23):7958-63. PubMed ID: 19857971
[TBL] [Abstract][Full Text] [Related]
2. m-Carborane bisphenol structure as a pharmacophore for selective estrogen receptor modulators.
Ogawa T; Ohta K; Yoshimi T; Yamazaki H; Suzuki T; Ohta S; Endo Y
Bioorg Med Chem Lett; 2006 Aug; 16(15):3943-6. PubMed ID: 16735120
[TBL] [Abstract][Full Text] [Related]
3. Enhanced estrogen receptor beta (ERβ) selectivity of fluorinated carborane-containing ER modulators.
Ohta K; Ogawa T; Kaise A; Endo Y
Bioorg Med Chem Lett; 2013 Dec; 23(24):6555-8. PubMed ID: 24268550
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of p-carborane bisphenols and their derivatives: structure-activity relationship for estrogenic activity.
Ogawa T; Ohta K; Iijima T; Suzuki T; Ohta S; Endo Y
Bioorg Med Chem; 2009 Feb; 17(3):1109-17. PubMed ID: 19141368
[TBL] [Abstract][Full Text] [Related]
5. Potent androgen antagonists based on carborane as a hydrophobic core structure.
Fujii S; Goto T; Ohta K; Hashimoto Y; Suzuki T; Ohta S; Endo Y
J Med Chem; 2005 Jul; 48(14):4654-62. PubMed ID: 16000001
[TBL] [Abstract][Full Text] [Related]
6. A novel carborane analog, BE360, with a carbon-containing polyhedral boron-cluster is a new selective estrogen receptor modulator for bone.
Hirata M; Inada M; Matsumoto C; Takita M; Ogawa T; Endo Y; Miyaura C
Biochem Biophys Res Commun; 2009 Mar; 380(2):218-22. PubMed ID: 19159615
[TBL] [Abstract][Full Text] [Related]
7. Estrogenic activity of B-fluorinated o-carborane-1,2-bisphenol synthesized via S(N)Ar reaction.
Ohta K; Ogawa T; Endo Y
Bioorg Med Chem Lett; 2012 Jul; 22(14):4728-30. PubMed ID: 22695130
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and evaluation of 17alpha-20E-21-(4-substituted phenyl)-19-norpregna-1,3,5(10),20-tetraene-3,17beta-diols as probes for the estrogen receptor alpha hormone binding domain.
Hanson RN; Lee CY; Friel CJ; Dilis R; Hughes A; DeSombre ER
J Med Chem; 2003 Jul; 46(14):2865-76. PubMed ID: 12825929
[TBL] [Abstract][Full Text] [Related]
9. ER subtype selectivity of m-carborane-containing phenols: C-alkyl groups on the m-carborane cage enhance ERα selectivity.
Ohta K; Ogawa T; Kato K; Oda A; Endo Y
Bioorg Med Chem Lett; 2019 Aug; 29(16):2290-2293. PubMed ID: 31248773
[TBL] [Abstract][Full Text] [Related]
10. Estrogen receptor modulators: identification and structure-activity relationships of potent ERalpha-selective tetrahydroisoquinoline ligands.
Renaud J; Bischoff SF; Buhl T; Floersheim P; Fournier B; Halleux C; Kallen J; Keller H; Schlaeppi JM; Stark W
J Med Chem; 2003 Jul; 46(14):2945-57. PubMed ID: 12825935
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and characterization of 3-arylquinazolinone and 3-arylquinazolinethione derivatives as selective estrogen receptor beta modulators.
Güngör T; Chen Y; Golla R; Ma Z; Corte JR; Northrop JP; Bin B; Dickson JK; Stouch T; Zhou R; Johnson SE; Seethala R; Feyen JH
J Med Chem; 2006 Apr; 49(8):2440-55. PubMed ID: 16610787
[TBL] [Abstract][Full Text] [Related]
12. Design and synthesis of carborane-containing androgen receptor (AR) antagonist bearing a pyridine ring.
Ohta K; Goto T; Fijii S; Suzuki T; Ohta S; Endo Y
Bioorg Med Chem; 2008 Sep; 16(17):8022-8. PubMed ID: 18707892
[TBL] [Abstract][Full Text] [Related]
13. Symmetric 4,4'-(piperidin-4-ylidenemethylene)bisphenol derivatives as novel tunable estrogen receptor (ER) modulators.
Sato M; Ohta K; Kaise A; Aoto S; Endo Y
Bioorg Med Chem; 2016 Mar; 24(5):1089-94. PubMed ID: 26822566
[TBL] [Abstract][Full Text] [Related]
14. From ligand structure to biological activity: modified estratrienes and their estrogenic and antiestrogenic effects in MCF-7 cells.
Brooks SC; Skafar DF
Steroids; 2004 Jun; 69(6):401-18. PubMed ID: 15219790
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of novel m-carborane-containing estrogen receptor partial agonists as SERM candidates.
Ohta K; Ogawa T; Kaise A; Endo Y
Bioorg Med Chem Lett; 2015 Aug; 25(16):3213-6. PubMed ID: 26077489
[TBL] [Abstract][Full Text] [Related]
16. Antiestrogenic and DNA damaging effects induced by tamoxifen and toremifene metabolites.
Liu X; Pisha E; Tonetti DA; Yao D; Li Y; Yao J; Burdette JE; Bolton JL
Chem Res Toxicol; 2003 Jul; 16(7):832-7. PubMed ID: 12870885
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and evaluation of (17alpha,20Z)-21-(4-substituted-phenyl)-19-norpregna-1,3,5(10),20-tetraene-3,17beta-diols as ligands for the estrogen receptor-alpha hormone binding domain: comparison with 20E-isomers.
Hanson RN; Friel CJ; Dilis R; Hughes A; DeSombre ER
J Med Chem; 2005 Jun; 48(13):4300-11. PubMed ID: 15974584
[TBL] [Abstract][Full Text] [Related]
18. Selective estrogen receptor modulators in the ruthenocene series. Synthesis and biological behavior.
Pigeon P; Top S; Vessières A; Huché M; Hillard EA; Salomon E; Jaouen G
J Med Chem; 2005 Apr; 48(8):2814-21. PubMed ID: 15828819
[TBL] [Abstract][Full Text] [Related]
19. Antiestrogenically active 1,1,2-tris(4-hydroxyphenyl)alkenes without basic side chain: synthesis and biological activity.
Lubczyk V; Bachmann H; Gust R
J Med Chem; 2003 Apr; 46(8):1484-91. PubMed ID: 12672249
[TBL] [Abstract][Full Text] [Related]
20. Novel estrogen receptor (ER) modulators containing various hydrophobic bent-core structures.
Ohta K; Ogawa T; Kaise A; Endo Y
Bioorg Med Chem; 2014 Jul; 22(13):3508-14. PubMed ID: 24837157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
